These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 8817416)

  • 21. Hypofractionated stereotactic radiotherapy in the management of recurrent or residual medulloblastoma/PNET.
    Saran F; Baumert BG; Creak AL; Warrington AP; Ashley S; Traish D; Brada M
    Pediatr Blood Cancer; 2008 Mar; 50(3):554-60. PubMed ID: 17941071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children's Cancer Group study.
    Ris MD; Packer R; Goldwein J; Jones-Wallace D; Boyett JM
    J Clin Oncol; 2001 Aug; 19(15):3470-6. PubMed ID: 11481352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of patients of high-risk group of medulloblastoma with the adjuvant lomustine, cisplatin, and vincristine chemotherapy.
    Rutkauskiene G; Labanauskas L
    Medicina (Kaunas); 2005; 41(12):1026-34. PubMed ID: 16401959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current diagnostic and therapeutic management of CNS metastasis in childhood primitive neuroectodermal tumors and ependymomas.
    Scheurlen W; Kühl J
    J Neurooncol; 1998; 38(2-3):181-5. PubMed ID: 9696369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy.
    Packer RJ; Sutton LN; Elterman R; Lange B; Goldwein J; Nicholson HS; Mulne L; Boyett J; D'Angio G; Wechsler-Jentzsch K
    J Neurosurg; 1994 Nov; 81(5):690-8. PubMed ID: 7931615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The treatment of malignant brain tumors in infants and very young children: an update of the Pediatric Oncology Group experience.
    Duffner PK; Horowitz ME; Krischer JP; Burger PC; Cohen ME; Sanford RA; Friedman HS; Kun LE
    Neuro Oncol; 1999 Apr; 1(2):152-61. PubMed ID: 11554387
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study.
    Packer RJ; Goldwein J; Nicholson HS; Vezina LG; Allen JC; Ris MD; Muraszko K; Rorke LB; Wara WM; Cohen BH; Boyett JM
    J Clin Oncol; 1999 Jul; 17(7):2127-36. PubMed ID: 10561268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91.
    Kortmann RD; Kühl J; Timmermann B; Mittler U; Urban C; Budach V; Richter E; Willich N; Flentje M; Berthold F; Slavc I; Wolff J; Meisner C; Wiestler O; Sörensen N; Warmuth-Metz M; Bamberg M
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):269-79. PubMed ID: 10661332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcome of medulloblastoma in children treated with reduced-dose radiation therapy plus adjuvant chemotherapy.
    Sirachainan N; Nuchprayoon I; Thanarattanakorn P; Pakakasama S; Lusawat A; Visudibhan A; Dhanachai M; Larbcharoensub N; Amornfa J; Shotelersuk K; Katanyuwong K; Tangkaratt S; Hongeng S
    J Clin Neurosci; 2011 Apr; 18(4):515-9. PubMed ID: 21310618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiagent chemotherapy studied in a xenograft model of medulloblastoma/primitive neuroectodermal tumour: analysis of the VETOPEC regimen.
    White L; Sterling-Levis K
    J Clin Neurosci; 2008 Jan; 15(1):49-54. PubMed ID: 18036819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carboplatin in childhood medulloblastoma/PNET: feasibility of an in vivo sensitivity test in an "up-front" study.
    Mastrangelo R; Lasorella A; Riccardi R; Colosimo C; Iavarone A; Tornesello A; Mastrangelo S; Ausili-Cefaro G; Di Rocco C
    Med Pediatr Oncol; 1995 Mar; 24(3):188-96. PubMed ID: 7838041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Longterm treatment results of childhood medulloblastoma by craniospinal irradiation in supine position.
    Slampa P; Pavelka Z; Dusek L; Hynkova L; Sterba J; Ondrova B; Princ D; Novotny T; Kostakova S
    Neoplasma; 2007; 54(1):62-7. PubMed ID: 17203894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary postoperative chemotherapy without radiotherapy for treatment of brain tumours other than ependymoma in children under 3 years: results of the first UKCCSG/SIOP CNS 9204 trial.
    Grundy RG; Wilne SH; Robinson KJ; Ironside JW; Cox T; Chong WK; Michalski A; Campbell RH; Bailey CC; Thorp N; Pizer B; Punt J; Walker DA; Ellison DW; Machin D;
    Eur J Cancer; 2010 Jan; 46(1):120-33. PubMed ID: 19818598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence and severity of postoperative cerebellar mutism syndrome in children with medulloblastoma: a prospective study by the Children's Oncology Group.
    Robertson PL; Muraszko KM; Holmes EJ; Sposto R; Packer RJ; Gajjar A; Dias MS; Allen JC;
    J Neurosurg; 2006 Dec; 105(6 Suppl):444-51. PubMed ID: 17184075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study.
    Zeltzer PM; Boyett JM; Finlay JL; Albright AL; Rorke LB; Milstein JM; Allen JC; Stevens KR; Stanley P; Li H; Wisoff JH; Geyer JR; McGuire-Cullen P; Stehbens JA; Shurin SB; Packer RJ
    J Clin Oncol; 1999 Mar; 17(3):832-45. PubMed ID: 10071274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I).
    Tait DM; Thornton-Jones H; Bloom HJ; Lemerle J; Morris-Jones P
    Eur J Cancer; 1990 Apr; 26(4):464-9. PubMed ID: 2141512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Feasibility of metronomic maintenance chemotherapy following high-dose chemotherapy for malignant central nervous system tumors.
    Choi LM; Rood B; Kamani N; La Fond D; Packer RJ; Santi MR; Macdonald TJ
    Pediatr Blood Cancer; 2008 May; 50(5):970-5. PubMed ID: 17941070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-dose chemotherapy with autologous stem cell rescue for children with high risk and recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors.
    Pérez-Martínez A; Lassaletta A; González-Vicent M; Sevilla J; Díaz MA; Madero L
    J Neurooncol; 2005 Jan; 71(1):33-8. PubMed ID: 15719272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medullomyoblastoma treated with craniospinal radiation and adjuvant chemotherapy: Report of 4 cases and review of the literature.
    Benson R; Mallick S; Bhanu Prasad V; Haresh KP; Gupta S; Julka PK; Rath GK
    J Egypt Natl Canc Inst; 2015 Jun; 27(2):109-11. PubMed ID: 25936510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiotherapy for medulloblastoma in children: a perspective on current international clinical research efforts.
    Freeman CR; Taylor RE; Kortmann RD; Carrie C
    Med Pediatr Oncol; 2002 Aug; 39(2):99-108. PubMed ID: 12116057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.